Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal - Announcement under Regulation 30 (LODR)-Analy...

02-Sep-2026|10:25AM

Intimation of Analyst and Investor meet pursuant to regulations 30 of SEBI

Hikal - Analysts/Institutional Investor Meet/Con. Cal...

02-Sep-2026|10:19AM

Hikal Limited has informed the Exchange about Schedule of meet

Hikal - Copy of Newspaper Publication

01-Sep-2026|1:53PM

Hikal Limited has informed the Exchange about Copy of Newspaper Publication

Hikal - General Updates

31-Aug-2026|5:04PM

Hikal Limited has informed the Exchange about General Updates

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug95.79271.61
Aarti Drug431.653,939.67
Aarti Pharma858.807,787.58
Abbott India26,065.0055,386.31
Accent Micro617.801,482.04
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..80.581.18
Tata Sm..73.030.58
Motilal..0.020.05
Bandhan..0.010.05
Motilal..0.000.00
More

Board Meetings

DatePurpose
06/08/2026Quarterly Results
27/05/2026Audited Results & F..
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
More